Emerged from stealth Oct 2025. Explicitly positioned as "AI-powered psychiatry platform" — closest competitor to Psynk's positioning.
$1.25B unicorn explicitly uses psychiatry as go-to-market beachhead. MultiCare enterprise rollout began Feb 2026.
$17M seed (Mar 2026) for "Sage" — clinician-supervised AI for complex mental health. Targets large BH organizations.
Ambient listening with structured MSE documentation, risk assessment extraction, and bidirectional EHR integration.
Behavioral health software startup. Building AI-native "operating system for BH": unified EHR + RCM + CRM. 60-70% faster documentation. Direct competitor — watch closely.
First disclosed acquisition. Claude for Healthcare launched Jan 2026 with HIPAA-ready enterprise platform.
Combined with KLAS #1 BH EHR = potent outpatient bundle. GA planned mid-late 2026. $17B PE backing.
BH EHR adds built-in ambient scribe that generates notes within templates. Integrated EHR approach.
Eleos is outpatient/SUD-heavy — no inpatient psych workflow depth, no nursing shift diaries, no Joint Commission-native compliance.
Founded by a psychiatrist — similar domain DNA to Psynk. But focused on outpatient private practice, not inpatient hospital workflows. No nursing documentation. Small team, early stage.
Upheal targets outpatient private practice only. No inpatient, no nursing workflows, no Joint Commission compliance. Their EHR-replacement strategy mirrors Psynk's long-term vision but in a different care setting.
Qualifacts is a broad BH EHR, not psychiatry-specialized. Their AI is an EHR-addon, not workflow-native. No nursing shift diaries. Slow PE-backed innovation cycle.
SimplePractice is outpatient-only, solo-practice-focused. Completely different market from inpatient psychiatric hospitals. No threat to Psynk's core market.
Abridge is a general-purpose scribe selling to large health systems. No BH-specific workflows. But $778M war chest + stated acquisition intent means they could acquire into BH space.
Ambience is the closest general-purpose threat — they claim psychiatry support and are pushing into inpatient. But no nursing diaries, no shift handoff, no Joint Commission-native compliance. Generic platform, not psych-native.
Suki is voice-first and generalist. No BH workflows, no inpatient psych. athenahealth partnership could become indirect competition if athena expands BH AI.
OpenEvidence is clinical decision support, not documentation. Different product category entirely. Threat is if they expand into documentation or if hospitals bundle decision support + documentation.
Epic dominates large health systems but Psynk targets facilities on constrained EHRs (Aura). Epic's BH is generic, not psych-native. Different customer segment entirely.
Oracle is distracted by VA problems and broad EHR transition. BH module is generic. Not a near-term threat to specialized psych facilities.
athena targets outpatient BH practices, not inpatient psych hospitals. Their ambient scribe is generic (via Suki). But BH EHR + free AI scribe is potent for outpatient.
Consumer product, not clinical documentation. Psychiatric liability exposure is a negative signal. No institutional workflow capability.
Anthropic is an enabler (Psynk could build on Claude), not a direct competitor. Infrastructure layer, not workflow. Potential strategic partner.
Blossom is the closest competitor to Psynk's long-term vision. Key question: are they targeting outpatient psychiatry or inpatient? Psynk's inpatient depth (nursing shifts, daily progress notes, Joint Commission compliance) remains differentiated. MONITOR CLOSELY.
Different product category (clinical supervision vs. documentation). Not directly competing on documentation workflow. Worth watching for convergence.
Likely outpatient-focused. No evidence of inpatient workflow, nursing diaries, or Joint Commission compliance. Psynk's hospital embedding is the moat.
Template-driven approach, not workflow-native. No inpatient or nursing features. RCM angle is interesting but likely outpatient billing.
$41M from a16z is serious capital for BH. But they just launched — Psynk has real hospital workflow knowledge from Ocean View. Ease Health's exact product scope is unclear; if it's practice management + documentation, they'll compete broadly. Psynk's advantage is depth in inpatient psych, which takes years to build without hospital partnerships.
PIMSY is a mid-market BH EHR, not psych-specialized. Ambient scribe is a feature add-on, not a workflow-native product.